Courriel : bd@sidmexinovia.com
Téléphone : +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Idromet 6 mg Injection
Manufacturer/Marketed By : Aureate Healthcare Pvt Ltd
$28.33 $14.88
Idromet 6 mg Injection is an essential treatment designed to prevent skeletal complications, such as fractures, in patients with breast cancer that has metastasized to the bones. This injectable medication,...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Ibandronic acid 6 mg
Active Pharmaceutical Ingredient
Idromet 6 mg Injection
28,33 $US
14,88 $US
Idromet 6 mg Injection is an essential treatment designed to prevent skeletal complications, such as fractures, in patients with breast cancer that has metastasized to the bones. This injectable medication, containing Ibandronic Acid, is also indicated for managing osteoporosis in postmenopausal women at an elevated risk of bone fractures. By inhibiting bone resorption, Idromet effectively helps strengthen bone density and reduce the likelihood of spinal fractures, although it is important to note that it does not significantly lower the risk of femoral neck fractures. Patients should be aware of potential side effects, including gastrointestinal disturbances and renal concerns, making regular monitoring crucial during therapy. It is vital to discuss your complete medical history with your healthcare provider before starting treatment to ensure Idromet is appropriate for your individual health needs. This medication represents a significant advancement in the management of bone health for those affected by cancer and osteoporosis. With Idromet, patients can take proactive steps towards preserving their skeletal integrity and overall quality of life.
Active Pharmaceutical Ingredient
Uses
• Idromet 6 mg injection is utilized to prevent skeletal events in patients diagnosed with breast cancer that has metastasized to the bones. This treatment helps reduce the risk of fractures and other bone complications that may require medical intervention. By addressing these issues proactively, Idromet 6 mg injection supports overall bone health in cancer patients. It is particularly important for those who are at higher risk due to their condition.
• Another important application of Idromet 6 mg injection is the prevention of osteoporosis in postmenopausal women. After menopause, women experience a decline in bone density, making them more susceptible to fractures. Idromet 6 mg injection helps mitigate this risk by preserving bone strength and integrity. This preventive measure is vital for maintaining a healthy lifestyle and minimizing the chances of serious bone-related issues.
• Idromet 6 mg injection is also effective in managing bone health in patients undergoing certain cancer treatments. These treatments can lead to bone density loss, and Idromet 6 mg injection serves as a protective measure against this adverse effect. By using this injection, healthcare providers can help patients maintain better bone health during their cancer journey. This aspect of care is crucial for enhancing the quality of life for those affected by cancer.
• Additionally, Idromet 6 mg injection is indicated for patients with conditions that put them at risk for skeletal-related events. This includes individuals with specific cancer types that are known to impact bone health negatively. The administration of Idromet 6 mg injection in these cases can help prevent complications, ensuring that patients remain as active and healthy as possible. This proactive approach is essential for managing bone health in vulnerable populations.
Benefits
Idromet 6 mg Vial belongs to a group of medicines called 'bisphosphonates' which are used for the prevention of osteoporosis after menopause. It is used in adults to prevent skeletal events such as pathological fractures and bone complications requiring surgery or radiotherapy in patients with bone metastases or breast cancer. Ibandronic Acid Injection 6 mg can also be used to reduce hypocalcaemia (a high level of calcium in the blood). Idromet 6 mg Injection works by suppressing the activity of the osteoclasts and making the bones stronger. It helps reduce the risk of fracturing and helps reduce pain. Idromet 6 mg can reverse bone loss by increasing bone mass and stopping further bone loss.
Side Effects
Most side effects do not require medical attention and will go away as your body gets used to the medicine. Tell your doctor or health care professional if any of these symptoms get serious or if they bother you for a long time.
Most Common Side Effects
• Fever
• Tiredness
• Hives
• Nausea
• Indigestion
• Diarrhoea
• Heartburn
• Joint and Muscle Pain
Common Side Effects
• Dizziness
• Inflammation in Eye
• Stomach Pain
• Irritation in Tongue, Lips, and Throat
• Asthma
• Vomiting
How To Use
Idromet 6 mg Injection is administered by a doctor or nurse in a hospital or clinic setting. The appropriate dosage and frequency of use will be determined by your doctor, taking into account the specific condition being treated. You must follow your doctor's instructions exactly when taking this medicine. Failure to do so or taking an excessive amount may result in serious side effects. The beneficial effects of this medicine may take several weeks or months to manifest, but it is important not to stop taking it unless instructed to do so by your doctor. It is advised to avoid alcohol as it may increase the risk of liver damage. Self-administration of this Ibandronic Acid Injection 6 mg is strictly prohibited.
Safety Advice
• Alcohol: Drinking alcohol while taking Idromet Injection is generally not recommended. It can increase the risk of liver damage, so it is best to avoid alcohol or limit the amount of alcohol you drink while you are taking any of the medicines.
• Kidney: No dose adjustment is necessary for patients with mild or moderate kidney disease, where creatinine clearance is equal to or greater than 30 ml/min. Severe kidney disease patients do not use this Idromet 6 mg.
• Breastfeeding: Breastfeeding while taking Ibandronic Acid Injection 6 mg is not recommended. It is possible that Idromet 6 mg may pass into breast milk and harm a baby. If you are breastfeeding and taking Idromet 6 mg, it is important that you talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Liver: Ibandronic Acid Injection 6 mg is considered safe for use in liver disease patients. No dose adjustment is needed for such a type of patient.
• Pregnancy: The use of Anti-cancer Drug Idromet during pregnancy may be unsafe as there is some evidence from animal studies that it may harm the developing foetus. However, it is important to discuss the potential risks and benefits of taking Idromet Injection during pregnancy with your doctor if you are pregnant or planning to become pregnant. Your doctor can help you make the best decision for you and the health of your baby.
• Driving: Idromet 6 mg Injection does not usually affect your ability to drive.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.